You just read:

Analysis Shows Novartis Drug TOBI® Associated With Reduced Mortality in Cystic Fibrosis Patients With Common Lung Infection

News provided by

Novartis Pharmaceuticals Corporation

Oct 21, 2010, 04:05 ET